603538.SS
603538.SS
CNE100002Y25
NINGBO MENOVO PHARMACEUTICAL CO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.503.122.564 1.372.855.273
9.5%
Cost of Revenue 976.417.155 925.126.995
5.5%
Gross Profit 526.705.409 447.728.278
17.6%
325.999.087 302.819.943
7.7%
Operating Income 200.706.322 144.908.334
38.5%
Pretax Income 129.776.697 86.963.729
49.2%
Net Income Common Stockholders 102.229.353 66.806.624
53.0%
-- --
--
-- --
--
ende